Stock Comparison · Live Data
LLY vs NVO
Side-by-side comparison of Eli Lilly & Co. (LLY), Novo-Nordisk A/S (NVO) — live price, market cap, day change, and sector classification.
LLY vs NVO — which stock is the better buy?
Eli Lilly & Co. (LLY) leads this comparison by market capitalization at $862.01B. NVO is today's top mover with a +1.39% move, while NVO sees the highest trading volume at 15.10M shares.
Whether LLY vs NVO is the better investment for your portfolio depends on your time horizon, risk tolerance, and existing exposure. ArbibX runs Claude AI across thousands of US stocks daily and surfaces the most actionable picks with confidence scores and target prices. For a personalized analysis on LLY vs NVO, use the in-app "Ask Claude" assistant — it sees the live prices from this page plus your portfolio context.
Per-stock breakdown
- LLY — Eli Lilly & Co. trades at $969.38, day change +0.63%, pharmaceutical preparations sector, market cap $862.01B.
- NVO — Novo-Nordisk A/S trades at $44.49, day change +1.39%, market cap $194.57B.
Frequently asked
Which is the better stock — LLY vs NVO?
It depends on your goals. Eli Lilly & Co. (LLY) has the larger market cap at $862.01B. Today NVO is the strongest performer (+1.39%). For a qualitative read on each name use the AI Top 15 tab on ArbibX.
What is the current price of LLY and NVO?
LLY is trading at $969.38 (+0.63% on the day). NVO is trading at $44.49 (+1.39% on the day). Live prices update every minute on the ArbibX terminal.
How does ArbibX compare stocks?
ArbibX pulls live snapshot data from Polygon.io and pairs it with Claude-powered AI analysis. Comparison pages show price, market cap, day change, sector, and key technicals side by side. The deeper analysis (target prices, signals, risk notes) lives on each ticker's dedicated page.
Not financial advice · For informational purposes only · Data via Polygon.io